Gastrointestinal Endoscopy
Volume 72, Issue 5 , Pages 1089-1094, November 2010

EUS-guided tattooing before laparoscopic distal pancreatic resection (with video)

Received 13 May 2010; accepted 16 July 2010.

Background

Precise localization of small pancreatic tumors during laparoscopic distal pancreatectomy (LDP) can be difficult because of decreased tactile ability of laparoscopy and the homogeneous appearance of the pancreas and surrounding retroperitoneal fat. Precise localization of the lesion is critical to achieving adequate margins of resection and preserving healthy pancreatic tissue. EUS-guided fine-needle tattooing (EUS-FNT) of a pancreatic lesion before LDP has been described in single case reports, but no large series have reported its effectiveness in patients undergoing LDP.

Objective

To assess the feasibility, safety, and efficacy of EUS-FNT in consecutive patients undergoing LDP.

Design

Retrospective cohort study.

Setting

Tertiary-care referral hospital.

Patients

This study involved 30 consecutive patients who underwent LDP from 2008 to 2010. Thirteen had EUS-FNT followed by LDP, and 17 had LDP alone.

Interventions

LDP or EUS-FNT with a sterile carbon-particle tattoo followed by LDP.

Main Outcome Measurements

The following features were examined: the technical success and complication rates of EUS-FNT, visibility of the tattoo at the time of laparoscopy, durability of the tattoo, and pathologic absence of tumor at the resection margin.

Results

The final pathology of pancreatic lesions of patients who had EUS-FNT was similar to those who had LDP alone. The median resected tumor size was significantly larger for the LDP-alone patients (median 4.0 cm vs 1.3 cm; P = .03). Thirty-one percent (4/13) of lesions in the EUS-FNT group were not visualized by prior preoperative pancreatic protocol CT. EUS-FNT was feasible in all 13 patients at laparoscopy, with R0 resection and negative final pathology margins in all cases. The tattoo was visible in all 13 EUS-FNT cases, with mean time from EUS-FNT to surgery of 20.3 days (range, 3-69 days). There were no significant complications associated with EUS-FNT.

Limitations

Small, retrospective, single-center study.

Conclusions

Preoperative EUS-FNT of lesions was technically feasible and safe, and it assisted in the localization of lesions in patients before LDP. The carbon particle tattoo was durable and visible in all cases.

Abbreviations: EUS-FNT, EUS-guided fine-needle tattooing, EUS-FNA, EUS-guided fine needle aspiration, LDP, laparoscopic distal pancreatectomy

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 DISCLOSURE: All authors disclosed no financial relationships relevant to this publication.

PII: S0016-5107(10)01893-6

doi:10.1016/j.gie.2010.07.023

Gastrointestinal Endoscopy
Volume 72, Issue 5 , Pages 1089-1094, November 2010